Cancer remains one of the most formidable challenges in modern medicine, with treatment resistance and relapse posing significant hurdles.  Recent research highlights the potential of combining Bromodomain and Extra-Terminal (BET) protein inhibition with Poly(ADP-ribose) polymerase (PARP) inhibitors to enhance… How BET Repression and PARP Inhibition Can Combat Cancer—Data from FCG